title: Part IV. Human infections and antibiotic resistance.
authors.affiliation: National Institute for Communicable Diseases. pennyc@nicd.ac.za
authors.forename: P
authors.initials: P
authors.lastname: Crowther-Gibson
authors.forename: N
authors.initials: N
authors.lastname: Govender
authors.forename: D A
authors.initials: DA
authors.lastname: Lewis
authors.forename: C
authors.initials: C
authors.lastname: Bamford
authors.forename: A
authors.initials: A
authors.lastname: Brink
authors.forename: A
authors.initials: A
authors.lastname: von Gottberg
authors.forename: K
authors.initials: K
authors.lastname: Klugman
authors.forename: M
authors.initials: M
authors.lastname: du Plessis
authors.forename: A
authors.initials: A
authors.lastname: Fali
authors.forename: B
authors.initials: B
authors.lastname: Harris
authors.forename: K
authors.initials: K
authors.lastname: Keddy
authors.forename: M
authors.initials: M
authors.lastname: Botha
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology; D024881:Drug Resistance, Bacterial; D006293:Health Promotion / Q000458:organization & administration*; D006801:Humans; D009313:National Health Programs / Q000458:organization & administration; D055553:Prescription Drugs / Q000627:therapeutic use*; D011320:Primary Health Care / Q000458:organization & administration*; D013019:South Africa
chemical_list: D000900:Anti-Bacterial Agents; D055553:Prescription Drugs